SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041851
Filing Date
2023-08-11
Accepted
2023-08-11 16:09:22
Documents
66
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q revb-20230630.htm   iXBRL 10-Q 2153428
2 EX-31.1 revb-ex31_1.htm EX-31.1 41918
3 EX-31.2 revb-ex31_2.htm EX-31.2 41978
4 EX-32.1 revb-ex32_1.htm EX-32.1 15076
5 EX-32.2 revb-ex32_2.htm EX-32.2 14953
  Complete submission text file 0000950170-23-041851.txt   8203033

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT revb-20230630_pre.xml EX-101.PRE 431419
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT revb-20230630_def.xml EX-101.DEF 333526
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT revb-20230630_cal.xml EX-101.CAL 31955
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT revb-20230630.xsd EX-101.SCH 61552
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT revb-20230630_lab.xml EX-101.LAB 466915
60 EXTRACTED XBRL INSTANCE DOCUMENT revb-20230630_htm.xml XML 1278673
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

IRS No.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39603 | Film No.: 231164140
SIC: 2834 Pharmaceutical Preparations